Peripheral neuropathy decisions — 2025

The Board granted service connection for sarcoidosis and non-arteritic ischemic optic neuropathy left eye, both based on the Veteran's presumed toxic exposure under the PACT Act.

The Board remands the claims for service connection for peripheral neuropathy of the right lower and bilateral upper extremities to obtain a more complete medical opinion.

The Veteran was granted a 20 percent rating for right upper extremity CIDP prior to March 30, 2018, and a 40 percent rating from March 30, 2018, to October 27, 2018; however, the claim for a rating in excess of 40 percent was denied.

The appeal for service connection for various conditions, including diabetes type II and peripheral neuropathy, was dismissed due to the Veteran's death during the pendency of the appeal.

The Board remands the claims for a new VA examination to determine the current nature and severity of the Veteran's diabetes mellitus type II (DMII) and associated bilateral lower extremity peripheral neuropathy.

The Board remands the issue of entitlement to service connection for neuropathy of the right and left feet due to an inadequate medical opinion.

The Board denied service connection for obstructive sleep apnea, insomnia, diabetes mellitus, type II, a kidney disability, an eye disability, bilateral lower extremities peripheral neuropathy, and bilateral upper extremities peripheral neuropathy as there was no evidence of an in-service injury or incurrence related to these conditions. The claims for service connection for bilateral hearing loss, arthritis, hypertension, headaches, and tinnitus were remanded for further development.

The Board remands the claims for service connection for COPD, Parkinson's disease, and peripheral neuropathy of all extremities to schedule examinations to determine if there is a relationship between these conditions and the Veteran's presumed exposure to herbicides during his service in Vietnam.

The Board remands the claims for service connection for peripheral neuropathy and traumatic encephalopathy to afford the Veteran VA examinations.

The Board denied increased ratings for lumbosacral strain, diabetes mellitus, type II, and tinnitus. The issues related to the right lower extremity sciatic nerve radiculopathy and peripheral neuropathy and left lower extremity peripheral neuropathy were remanded.

The Board remands the claims for service connection for low back disability, diabetes mellitus type II, and peripheral neuropathy of both upper and lower extremities to correct duty to assist errors related to the Veteran's reported toxic exposure at Fort McClellan.

The Board granted effective dates of September 17, 2012, for the cervical spine disability and associated neurological impairments, headache disability; November 29, 2018, for the lumbar spine disability and associated neurological impairments of the bilateral legs; April 22, 2019, for the psychiatric disability; and April 22, 2019, for the six separately-rated bilateral hip disabilities.

The Board remands the claims for service connection for diabetes mellitus type II, erectile dysfunction, and bilateral peripheral neuropathy due to a need for further development of evidence related to herbicide exposure.

The Board denied service connection for an acquired psychiatric disorder and granted service connection for a right knee disability. The ratings for tinnitus, limitation of flexion and extension of the right hip, impairment of the right hip, lumbar spine disability, and left ankle disability were also denied or granted as appropriate.

The Veteran's diabetic neuropathy of the sciatic nerve has been granted a 40 percent rating from January 17, 2021 to June 21, 2023.

The Board granted a compensable rating of 10 percent for the Veteran's service-connected meralgia paresthetica with lateral femoral cutaneous nerve neuropathy of the right thigh based on severe incomplete paralysis.

The Board remands the claims for additional development, specifically to obtain an adequate VA medical opinion regarding whether the Veteran's peripheral neuropathy is related to service, including considering in-service environmental exposures.

The Board remands the claims for service connection and a TDIU prior to August 21, 2014, due to the need for additional evidence.

The Board denied an initial disability rating higher than 20 percent for the service-connected left arm neuropathy from August 6, 2018.

The Board denied service connection for right lower and left upper extremity peripheral neuropathy, a rating in excess of 50 percent for posttraumatic stress disorder and depression, and an initial rating in excess of 10 percent for hypertension. However, the TDIU was granted.